Terms: = Germ cell tumor AND RBM10, GPATC9, 8241, ENSG00000182872, CTD-2522E6_5, GPATCH9, KIAA0122, P98175, MGC1132, DXS8237E, ZRANB5, MGC997 AND Staging
1986 results:
1. Analysis of 25 surgical cases of thymic neuroendocrine tumors and thymic carcinoma.
Midorikawa K; Miyahara S; Nishino N; Ueda Y; Waseda R; Shiraishi T; Sato T
J Cardiothorac Surg; 2024 Apr; 19(1):225. PubMed ID: 38627811
[TBL] [Abstract] [Full Text] [Related]
2. Impact of grade on workup of rectal neuroendocrine tumors: a retrospective cohort study : Grade impact on workup of rectal NETs.
Watanabe A; Rai S; Yip L; Brown CJ; Loree JM; Stuart HC
World J Surg Oncol; 2024 Apr; 22(1):98. PubMed ID: 38627724
[TBL] [Abstract] [Full Text] [Related]
3. Development and validation of a novel model to predict recurrence-free survival and melanoma-specific survival after sentinel lymph node biopsy in patients with melanoma: an international, retrospective, multicentre analysis.
Stassen RC; Maas CCHM; van der Veldt AAM; Lo SN; Saw RPM; Varey AHR; Scolyer RA; Long GV; Thompson JF; Rutkowski P; Keilholz U; van Akkooi ACJ; Verhoef C; van Klaveren D; Grünhagen DJ
Lancet Oncol; 2024 Apr; 25(4):509-517. PubMed ID: 38547894
[TBL] [Abstract] [Full Text] [Related]
4. [Clinical analysis of 12 cases of ovarian yolk sac tumor].
Liu J; Chu HJ; Shan YP; Song WJ; Chen AP
Zhonghua Fu Chan Ke Za Zhi; 2024 Mar; 59(3):210-214. PubMed ID: 38544450
[No Abstract] [Full Text] [Related]
5. The impact of multidisciplinary approaches on the outcomes of olfactory neuroblastoma treated with postoperative radiotherapy.
Tsutsumi Y; Omura K; Kijima Y; Kobayashi M; Fukasawa N; Takeda T; Ebihara T; Aoki S; Otori N; Kojima H; Aoki M
Cancer Med; 2024 Mar; 13(5):e6943. PubMed ID: 38497548
[TBL] [Abstract] [Full Text] [Related]
6. Assessment of Social Vulnerabilities of Care and Prognosis in Adult Ocular Melanomas in the US.
Mensah JA; Fei-Zhang DJ; Rossen JL; Rahmani B; Bentrem DJ; Stein JD; French DD
Ann Surg Oncol; 2024 May; 31(5):3302-3313. PubMed ID: 38418655
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic value of CT-based radiomics in grade 1-2 pancreatic neuroendocrine tumors.
Heo S; Park HJ; Kim HJ; Kim JH; Park SY; Kim KW; Kim SY; Choi SH; Byun JH; Kim SC; Hwang HS; Hong SM
Cancer Imaging; 2024 Feb; 24(1):28. PubMed ID: 38395973
[TBL] [Abstract] [Full Text] [Related]
8. Diagnosis and staging of small intestinal neuroendocrine tumors with CT enterography and PET with Gallium-68: preoperative risk stratification protocol.
Bonomi A; Fumagalli Romario U; Funicelli L; Conti G; Realis Luc M; Ceci F; Pozzi S; Radice D; Fazio N; Bertani E
Langenbecks Arch Surg; 2024 Feb; 409(1):63. PubMed ID: 38363374
[TBL] [Abstract] [Full Text] [Related]
9. Combined visual and quantitative assessment of somatostatin receptor scintigraphy for staging and restaging of neuroendocrine tumors.
Ueki Y; Otsuka H; Otani T; Kasai R; Otomi Y; Ikemitsu D; Azane S; Kunikane Y; Bando T; Matsuda N; Okada Y; Takayama T; Harada M
Jpn J Radiol; 2024 May; 42(5):519-535. PubMed ID: 38345724
[TBL] [Abstract] [Full Text] [Related]
10. Volumetric Parameters Derived from CXCR4-Directed PET/CT Predict Outcome in Patients with Gastrointestinal Neuroendocrine Carcinomas.
Michalski K; Schlötelburg W; Hartrampf P; Heinrich M; Serfling S; Buck AK; Werner RA; Kosmala A; Weich A
Mol Imaging Biol; 2024 Apr; 26(2):344-350. PubMed ID: 38332341
[TBL] [Abstract] [Full Text] [Related]
11. Split-bolus single-phase versus single-bolus split-phase CT acquisition protocols for staging in patients with testicular cancer: A retrospective study.
O'Regan PW; Dewhurst C; O'Mahony AT; O'Regan C; O'Leary V; O'Connor G; Ryan D; Maher MM; Young R
Radiography (Lond); 2024 Mar; 30(2):628-633. PubMed ID: 38330895
[TBL] [Abstract] [Full Text] [Related]
12. Impact of extra-nodal extension and AJCC lymph node staging in predicting recurrence following lymphadenectomy in patients with melanoma.
Downey J; Hamm J; Baliski C
Am J Surg; 2024 May; 231():120-124. PubMed ID: 38320886
[TBL] [Abstract] [Full Text] [Related]
13. Predicting Recurrence-Free and Overall Survival for Patients With Stage II Melanoma: The MIA Calculator.
Varey AHR; Li I; El Sharouni MA; Simon J; Dedeilia A; Ch'ng S; Saw RPM; Spillane AJ; Shannon KF; Pennington TE; Rtshiladze M; Stretch JR; Nieweg OE; van Akkooi A; Sullivan RJ; Boland GM; Gershenwald JE; van Diest PJ; Scolyer RA; Long GV; Thompson JF; Lo SN
J Clin Oncol; 2024 Apr; 42(10):1169-1180. PubMed ID: 38315961
[TBL] [Abstract] [Full Text] [Related]
14. A pancancer analysis of the clinical and genomic characteristics of multiple primary cancers.
Zhang B; He L; Zhou C; Cheng X; Li Q; Tang Y; Li F; Huang T; Tu S
Sci Rep; 2024 Jan; 14(1):2367. PubMed ID: 38287125
[TBL] [Abstract] [Full Text] [Related]
15. Pineal anlage tumor: clinical and diagnostic features, and rationales for treatment.
Obrecht-Sturm D; Pfaff E; Mynarek M; Bison B; Rodehüser M; Becker M; Kietz S; Pfister SM; Jones DT; Sturm D; von Deimling A; Sahm F; Kortmann RD; Schwarz R; Pietsch T; Fleischhack G; Rutkowski S
J Neurooncol; 2024 Jan; 166(2):359-368. PubMed ID: 38253790
[TBL] [Abstract] [Full Text] [Related]
16. Retinoblastoma treatment in a Brazilian population. Presentation and long-term results.
Bonanomi MTBC; de Almeida MTA; Hollaender MA; Bonanomi RC; Monteiro MLR
Cancer Med; 2024 Feb; 13(3):e6683. PubMed ID: 38243643
[TBL] [Abstract] [Full Text] [Related]
17. The impact of neo/adjuvant treatment choices on prognosis for surgically treated small-cell neuroendocrine carcinoma of the cervix.
Zhao D; Sun S; Yang Z; Wang P; Qiu H
Neoplasma; 2024 Feb; 71(1):70-76. PubMed ID: 38215035
[TBL] [Abstract] [Full Text] [Related]
18. Diagnostic value of [ 68 Ga]Ga-Pentixafor PET/CT in malignant melanoma: a pilot study.
Manafi-Farid R; Mahini M; Mirshahvalad SA; Fallahi B; Fard-Esfahani A; Emami-Ardekani A; Eftekhari M; Mousavi SA; Beiki D
Nucl Med Commun; 2024 Mar; 45(3):221-228. PubMed ID: 38214076
[TBL] [Abstract] [Full Text] [Related]
19. Competing Risk Model to Determine the Prognostic Factors for Patients with Gliosarcoma.
Chen M; Huang L; Wang F; Xu X; Xu X
World Neurosurg; 2024 Mar; 183():e483-e494. PubMed ID: 38157982
[TBL] [Abstract] [Full Text] [Related]
20. Comparison between whole-body magnetic resonance imaging and whole-body metaiodobenzylguanidine scintigraphy in the evaluation of primary tumor and metastases in neuroblastoma.
Rodrigues MMC; Lederman HM; Grossman I; Castiglioni MLV; Marchetti R; Grass DC; Luisi FAV; Caran EMM
Pediatr Blood Cancer; 2024 Mar; 71(3):e30820. PubMed ID: 38153317
[TBL] [Abstract] [Full Text] [Related]
[Next]